Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immuno-metabolic profile of patients with psychotic disorders and metabolic syndrome. Results from the FACE-SZ cohort.
Foiselle M, Barbosa S, Godin O, Wu CL, Boukouaci W, Andre M, Aouizerate B, Berna F, Barau C, Capdevielle D, Vidailhet P, Chereau I, Davidovic L, Dorey JM, Dubertret C, Dubreucq J, Faget C, Fond G, Leigner S, Llorca PM, Mallet J, Misdrahi D, Martinuzzi E, Passerieux C, Rey R, Pignon B, Urbach M, Schürhoff F, Glaichenhaus N, Leboyer M, Tamouza R; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Groups. Foiselle M, et al. Among authors: barau c. Brain Behav Immun Health. 2022 Mar 29;22:100436. doi: 10.1016/j.bbih.2022.100436. eCollection 2022 Jul. Brain Behav Immun Health. 2022. PMID: 35469211 Free PMC article.
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19.
Matuozzo D, Talouarn E, Marchal A, Zhang P, Manry J, Seeleuthner Y, Zhang Y, Bolze A, Chaldebas M, Milisavljevic B, Gervais A, Bastard P, Asano T, Bizien L, Barzaghi F, Abolhassani H, Abou Tayoun A, Aiuti A, Alavi Darazam I, Allende LM, Alonso-Arias R, Arias AA, Aytekin G, Bergman P, Bondesan S, Bryceson YT, Bustos IG, Cabrera-Marante O, Carcel S, Carrera P, Casari G, Chaïbi K, Colobran R, Condino-Neto A, Covill LE, Delmonte OM, El Zein L, Flores C, Gregersen PK, Gut M, Haerynck F, Halwani R, Hancerli S, Hammarström L, Hatipoğlu N, Karbuz A, Keles S, Kyheng C, Leon-Lopez R, Franco JL, Mansouri D, Martinez-Picado J, Metin Akcan O, Migeotte I, Morange PE, Morelle G, Martin-Nalda A, Novelli G, Novelli A, Ozcelik T, Palabiyik F, Pan-Hammarström Q, de Diego RP, Planas-Serra L, Pleguezuelo DE, Prando C, Pujol A, Reyes LF, Rivière JG, Rodriguez-Gallego C, Rojas J, Rovere-Querini P, Schlüter A, Shahrooei M, Sobh A, Soler-Palacin P, Tandjaoui-Lambiotte Y, Tipu I, Tresoldi C, Troya J, van de Beek D, Zatz M, Zawadzki P, Al-Muhsen SZ, Alosaimi MF, Alsohime FM, Baris-Feldman H, Butte MJ, Constantinescu SN, Cooper MA, Dalgard CL, Fellay J, Heath JR, Lau YL, Lifton RP, Maniatis T, Mogensen TH, v… See abstract for full author list ➔ Matuozzo D, et al. Genome Med. 2023 Apr 5;15(1):22. doi: 10.1186/s13073-023-01173-8. Genome Med. 2023. PMID: 37020259 Free PMC article.
A Multilevel Functional Study of a SNAP25 At-Risk Variant for Bipolar Disorder and Schizophrenia.
Houenou J, Boisgontier J, Henrion A, d'Albis MA, Dumaine A, Linke J, Wessa M, Daban C, Hamdani N, Delavest M, Llorca PM, Lançon C, Schürhoff F, Szöke A, Le Corvoisier P, Barau C, Poupon C, Etain B, Leboyer M, Jamain S. Houenou J, et al. Among authors: barau c. J Neurosci. 2017 Oct 25;37(43):10389-10397. doi: 10.1523/JNEUROSCI.1040-17.2017. Epub 2017 Oct 2. J Neurosci. 2017. PMID: 28972123 Free PMC article.
Contribution of common and rare damaging variants in familial forms of bipolar disorder and phenotypic outcome.
Courtois E, Schmid M, Wajsbrot O, Barau C, Le Corvoisier P, Aouizerate B, Bellivier F, Belzeaux R, Dubertret C, Kahn JP, Leboyer M, Olie E, Passerieux C, Polosan M, Etain B, Jamain S; and the FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD). Courtois E, et al. Among authors: barau c. Transl Psychiatry. 2020 Apr 28;10(1):124. doi: 10.1038/s41398-020-0783-0. Transl Psychiatry. 2020. PMID: 32345981 Free PMC article.
Natural killer cells in first-episode psychosis: an innate immune signature?
Tarantino N, Leboyer M, Bouleau A, Hamdani N, Richard JR, Boukouaci W, Ching-Lien W, Godin O, Bengoufa D, Le Corvoisier P, Barau C, Ledudal K, Debré P, Tamouza R, Vieillard V. Tarantino N, et al. Among authors: barau c. Mol Psychiatry. 2021 Sep;26(9):5297-5306. doi: 10.1038/s41380-020-01008-7. Epub 2021 Jan 17. Mol Psychiatry. 2021. PMID: 33456051
Low peripheral mitochondrial DNA copy number during manic episodes of bipolar disorders is associated with disease severity and inflammation.
Angrand L, Boukouaci W, Lajnef M, Richard JR, Andreazza A, Wu CL, Bouassida J, Rafik I, Foiselle M, Mezouad E, Naamoune S, Chami L, Mihoub O, Salah S, Benchaaben A, Le Corvoisier P, Barau C, Costes B, Yolken R, Crepeaux G, Leboyer M, Tamouza R. Angrand L, et al. Among authors: barau c. Brain Behav Immun. 2021 Nov;98:349-356. doi: 10.1016/j.bbi.2021.09.003. Epub 2021 Sep 6. Brain Behav Immun. 2021. PMID: 34500035 Free article.
HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder.
Boukouaci W, Lajnef M, Richard JR, Wu CL, Bouassida J, Rafik I, Foiselle M, Straczek C, Mezouad E, Naamoune S, Salah S, Bencharif MA, Ben Chaaben A, Barau C, Le Corvoisier P, Leboyer M, Tamouza R. Boukouaci W, et al. Among authors: barau c. Sci Rep. 2021 Oct 12;11(1):20260. doi: 10.1038/s41598-021-99732-9. Sci Rep. 2021. PMID: 34642395 Free PMC article.
Immune Signatures of Treatment-Resistant Schizophrenia: A FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) Study.
Leboyer M, Godin O, Terro E, Boukouaci W, Lu CL, Andre M, Aouizerate B, Berna F, Barau C, Capdevielle D, Clauss-Kobayashi J, Chereau I, D Amato T, Dubertret C, Dubreucq J, Fond G, Laouamri H, Leignier S, Lancon C, Llorca PM, Mallet J, Le Corvoisier P, Misdrahi D, Passerieux C, Rey R, Pignon B, Urbach M, Szoke A, Schürhoff F, Tamouza R; FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Groups. Leboyer M, et al. Among authors: barau c. Schizophr Bull Open. 2021 Apr 27;2(1):sgab012. doi: 10.1093/schizbullopen/sgab012. eCollection 2021 Jan. Schizophr Bull Open. 2021. PMID: 34901861 Free PMC article.
Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder.
Skorobogatov K, Autier V, Foiselle M, Richard JR, Boukouaci W, Wu CL, Raynal S, Carbonne C, Laukens K, Meysman P, Coppens V, le Corvoisier P, Barau C, De Picker L, Morrens M, Tamouza R, Leboyer M. Skorobogatov K, et al. Among authors: barau c. Brain Behav Immun Health. 2023 Jan 2;27:100584. doi: 10.1016/j.bbih.2022.100584. eCollection 2023 Feb. Brain Behav Immun Health. 2023. PMID: 36685639 Free PMC article.
64 results